Loading...
Market
How many clinical trials will be announced for Heparin as a treatment for cobra venom by December 31, 2024?
2
Resolution / Starting Odds
0 • 25%
1-2 • 25%
3-4 • 25%
5 or more • 25%
ClinicalTrials.gov and other official clinical trial registries
Story
Blood Thinner Heparin Shows Promise in Treating Cobra Venom, Study in Science Translational Medicine Finds
Jul 17, 2024, 07:35 PM
A global study suggests that the common blood thinner heparin could be used to treat cobra venom. Researchers have found that heparin, a widely used anticoagulant, shows promise in neutralizing cobra venom, potentially revolutionizing the treatment of cobra bites. This discovery could drastically reduce the severe injuries caused by cobra bites and improve survival rates. The study, published in Science Translational Medicine, highlights a new treatment strategy based on the molecular dissection of spitting cobra venom.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
1-2 countries • 25%
3-5 countries • 25%
6-10 countries • 25%
More than 10 countries • 25%
Only Cobra venom • 25%
Cobra and one other type of venom • 25%
Cobra and multiple other types of venom • 25%
Not effective against any venom • 25%
Less than 10% • 25%
10% to 25% • 25%
25% to 50% • 25%
More than 50% • 25%
Less than 5 • 25%
5 to 10 • 25%
10 to 15 • 25%
More than 15 • 25%
0-2 trials • 25%
3-5 trials • 25%
6-8 trials • 25%
More than 8 trials • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Completed with positive results • 25%
Completed with negative results • 25%
Not completed • 25%
Unknown/Other • 25%